APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Solid Dosage Pharmaceutical Formulation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Solid Dosage Pharmaceutical Formulation Industry Growth and Trends Forecast to 2032

22 December 202585 pages

Choose your research edition.

Industry ResearchOral Solid Dosage Pharmaceutical Formulation Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Solid Dosage Pharmaceutical Formulation Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Oral Solid Dosage Pharmaceutical Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Solid Dosage Pharmaceutical Formulation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Oral Solid Dosage Pharmaceutical Formulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Oral Solid Dosage Pharmaceutical Formulation market include Novartis, Merck, Eli Lilly, Pfizer, AbbVie, AstraZeneca, Gilead, Bristol-Myers Squibb and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Solid Dosage Pharmaceutical Formulation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Solid Dosage Pharmaceutical Formulation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Solid Dosage Pharmaceutical Formulation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Solid Dosage Pharmaceutical Formulation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Oral Solid Dosage Pharmaceutical Formulation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Solid Dosage Pharmaceutical Formulation Market by Company

Novartis

Merck

Eli Lilly

Pfizer

AbbVie

AstraZeneca

Gilead

Bristol-Myers Squibb

Boehringer Ingelheim

Oral Solid Dosage Pharmaceutical Formulation Segment by Type

Immediate Release

Extended Release

Others

Oral Solid Dosage Pharmaceutical Formulation Segment by Application

Hospital Pharmacy

Drug Stores

Retail Pharmacy

Others

Oral Solid Dosage Pharmaceutical Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Solid Dosage Pharmaceutical Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Solid Dosage Pharmaceutical Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Solid Dosage Pharmaceutical Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Oral Solid Dosage Pharmaceutical Formulation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2021-2026) Table 4. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2027-2032) Table 6. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2026) Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share Forecasted by Type (2027-2032) Table 11. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2026) Table 24. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share Forecasted by Application (2027-2032) Table 26. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Oral Solid Dosage Pharmaceutical Formulation Industry Trends Table 37. Oral Solid Dosage Pharmaceutical Formulation Industry Drivers Table 38. Oral Solid Dosage Pharmaceutical Formulation Industry Opportunities and Challenges Table 39. Oral Solid Dosage Pharmaceutical Formulation Industry Restraints Table 40. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Company (2021-2026) Table 42. Global Oral Solid Dosage Pharmaceutical Formulation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Oral Solid Dosage Pharmaceutical Formulation Key Company Headquarters & Area Served Table 44. Global Oral Solid Dosage Pharmaceutical Formulation Company, Product Type & Application Table 45. Global Oral Solid Dosage Pharmaceutical Formulation Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Oral Solid Dosage Pharmaceutical Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 52. Novartis Recent Development Table 53. Merck Company Information Table 54. Merck Business Overview Table 55. Merck Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 57. Merck Recent Development Table 58. Eli Lilly Company Information Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 62. Eli Lilly Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 67. Pfizer Recent Development Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AbbVie Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 72. AbbVie Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Gilead Company Information Table 79. Gilead Business Overview Table 80. Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Gilead Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 82. Gilead Recent Development Table 83. Bristol-Myers Squibb Company Information Table 84. Bristol-Myers Squibb Business Overview Table 85. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 87. Bristol-Myers Squibb Recent Development Table 88. Boehringer Ingelheim Company Information Table 89. Boehringer Ingelheim Business Overview Table 90. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 92. Boehringer Ingelheim Recent Development Table 93. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2026) Table 96. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Country (2027-2032) Table 98. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2026) Table 101. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2026) Table 106. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Country (2027-2032) Table 108. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2026) Table 111. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2026) Table 116. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Oral Solid Dosage Pharmaceutical Formulation Product Image Figure 3. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region: 2025 VS 2032 Figure 6. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2021-2032) Figure 7. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Immediate Release Image Figure 13. Global Immediate Release Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Extended Release Image Figure 15. Global Extended Release Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Type 2025 VS 2032 Figure 20. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2032) Figure 21. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2032) Figure 23. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2032) Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Drug Stores Image Figure 28. Global Drug Stores Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application 2025 VS 2032 Figure 35. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2032) Figure 36. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2032) Figure 38. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Oral Solid Dosage Pharmaceutical Formulation Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 45. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 48. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 51. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 54. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate Release
  • Extended Release
  • Others
Applications
  • Hospital Pharmacy
  • Drug Stores
  • Retail Pharmacy
  • Others
Companies covered
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • AbbVie
  • AstraZeneca
  • Gilead
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2021-2032)
  5. 1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2021-2026)
  6. 1.4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2027-2032)
  7. 1.5 Key Regions Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032)
  8. 1.5.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (2021-2032)
2 Oral Solid Dosage Pharmaceutical Formulation Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Immediate Release
  3. 2.1.2 Extended Release
  4. 2.1.3 Others
  5. 2.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
  6. 2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions
  10. 2.3.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Type (2021-2026)
3 Oral Solid Dosage Pharmaceutical Formulation Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacy
  3. 3.1.2 Drug Stores
  4. 3.1.3 Retail Pharmacy
  5. 3.1.4 Others
  6. 3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
  7. 3.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions
  11. 3.3.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Oral Solid Dosage Pharmaceutical Formulation Industry Trends
  2. 4.2 Oral Solid Dosage Pharmaceutical Formulation Industry Drivers
  3. 4.3 Oral Solid Dosage Pharmaceutical Formulation Industry Opportunities and Challenges
  4. 4.4 Oral Solid Dosage Pharmaceutical Formulation Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Oral Solid Dosage Pharmaceutical Formulation Revenue (2021-2026)
  2. 5.2 Global Oral Solid Dosage Pharmaceutical Formulation Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Oral Solid Dosage Pharmaceutical Formulation Key Company Headquarters & Area Served
  4. 5.4 Global Oral Solid Dosage Pharmaceutical Formulation Company, Product Type & Application
  5. 5.5 Global Oral Solid Dosage Pharmaceutical Formulation Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Oral Solid Dosage Pharmaceutical Formulation Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Oral Solid Dosage Pharmaceutical Formulation Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Oral Solid Dosage Pharmaceutical Formulation Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Gilead
  38. 6.7.1 Gilead Company Information
  39. 6.7.2 Gilead Business Overview
  40. 6.7.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  42. 6.7.5 Gilead Recent Developments
  43. 6.8 Bristol-Myers Squibb
  44. 6.8.1 Bristol-Myers Squibb Company Information
  45. 6.8.2 Bristol-Myers Squibb Business Overview
  46. 6.8.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  3. 7.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  3. 8.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  3. 10.3 South America Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst